Literature DB >> 16468503

Full-thickness chest wall resection for recurrent breast carcinoma: an institutional review and meta-analysis.

Colette R J Pameijer1, David Smith, Laurence E McCahill, David N Bimston, Lawrence D Wagman, Joshua D I Ellenhorn.   

Abstract

Locoregional recurrence of breast cancer can occur in up to 30 per cent of patients and has often been considered to indicate a poor prognosis. We reviewed our experience with full-thickness chest wall resection for recurrent breast cancer and conducted a meta-analysis of the English literature to determine patient characteristics and outcomes. Twenty-two women with isolated chest wall recurrence of breast cancer were treated between 1970 and 2000 at our institution. We reviewed their preoperative demographics, operative management and outcome, and combined our results with seven other English language studies. A majority of women (90%) underwent a mastectomy as initial management of their breast cancer. Only 18 per cent of patients had metastatic disease at the time of chest wall resection, and 71 per cent of patients had an R0 resection. The 5-year disease-free survival at City of Hope National Medical Center (COH) was 67 per cent and was 45 per cent for the entire group of 400 patients. The 5-year overall survival was 71 per cent for the COH group and 45 per cent for the entire group. Several studies reported prognostic factors, the most common being a better prognosis in patients with a disease-free interval greater than 24 months. Full-thickness chest wall resection for patients with isolated local recurrence of breast cancer can provide long-term palliation and even cure in some patients.

Entities:  

Mesh:

Year:  2005        PMID: 16468503

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Microsurgical chest wall reconstruction after oncologic resections.

Authors:  Michael Sauerbier; S Dittler; C Kreutzer
Journal:  Semin Plast Surg       Date:  2011-02       Impact factor: 2.314

2.  Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy.

Authors:  Timothy M Zagar; Kristin A Higgins; Edward F Miles; Zeljko Vujaskovic; Mark W Dewhirst; Robert W Clough; Leonard R Prosnitz; Ellen L Jones
Journal:  Radiother Oncol       Date:  2010-11-11       Impact factor: 6.280

3.  Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor.

Authors:  Tokiko Ito; Ken-ichi Ito; Toshihiro Okada; Koichi Murayama; Toru Hanamura; Toshiharu Kanai; Kazuma Maeno; Yasuhiro Mochizuki; Ryoichi Kondo; Jun Amano; Yoshiro Osada; Koji Asano
Journal:  Int J Clin Oncol       Date:  2010-08-19       Impact factor: 3.402

4.  Recurrent phyllodes sarcoma of breast with complete chest wall invasion; a multidisciplinary approach for radical resection.

Authors:  Ikram Ulhaq Chaudhry; Ammar Asban; Tarek Mahboub; Ali Arini
Journal:  BMJ Case Rep       Date:  2013-02-19

5.  Surgical reduction in chest wall disease to prolong survival in breast cancer patients: a retrospective study.

Authors:  Anjie Zhu; Zehui Yun; Miaoning You; Xiaoran Liu; Xu Liang; Ying Yan; Bin Shao; Hanfang Jiang; Lijun Di; Guohong Song; Huiping Li
Journal:  Gland Surg       Date:  2022-06

6.  Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia.

Authors:  A Auoragh; V Strnad; O J Ott; M W Beckmann; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-07-05       Impact factor: 3.621

7.  Response of cutaneous metastases from breast cancer to capecitabine.

Authors:  Kostandinos Sideras; Katie M Zahasky; Judith S Kaur
Journal:  Clin Med Oncol       Date:  2008-04-18

8.  Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence.

Authors:  Carmen C van der Pol; Albertus N van Geel; Marian B E Menke-Pluymers; Paul I M Schmitz; Titia E Lans
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.